BlinkBio

About:

BlinkBio employs specialized Bioorthogonal chemistries for the delivery of next generation medicines.

Website: http://www.blinkbioinc.com/

Top Investors: Florida Institute for the Commercialization of Florida Technology

Description:

BlinkBio is a biotechnology company formed to exploit Bioorthogonal Linker (“BLink”) chemistries through their Tunable Drug Conjugates (TDCs) platform for the treatment of oncology and other diseases. It has assembled a modular toolbox of components allowing the design of Tunable Drug Conjugates a new class of Drug Conjugate therapies for the treatment of cancer. The company's TDC platform comprises a modular set of ligands, linkers, and payloads with aligned characteristics to enable both rapid payload release in the tumor and rapid systemic clearance of the parent drug conjugate. It was founded in 2009 and is headquartered in Jupiter, Florida.